Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
6.415 USD | -1.91% | +3.85% | +14.69% |
Kurzporträt
Mitarbeiterzahl: 145
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Targeted Protein Degradation
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33.25% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33.25% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14.09.20 |
Kendra Adams
DFI | Director of Finance/CFO | 48 | 20.11.20 |
Chief Tech/Sci/R&D Officer | - | 01.01.21 | |
Stewart Fisher
CTO | Chief Tech/Sci/R&D Officer | 57 | 01.05.16 |
Leonard Reyno
CTO | Chief Tech/Sci/R&D Officer | 61 | 10.07.23 |
Courtney Solberg
IRC | Investor Relations Contact | - | - |
Mark Mossler
AUD | Comptroller/Controller/Auditor | 51 | 01.06.23 |
Scott Boyle
PRN | Corporate Officer/Principal | 46 | 01.01.22 |
Adrian Bignami
PRN | Corporate Officer/Principal | - | 01.04.21 |
Jolie Siegel
LAW | General Counsel | 47 | 01.06.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 01.12.15 |
Glenn Dubin
BRD | Director/Board Member | 67 | 12.03.21 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 01.12.15 |
Donna Grogan
BRD | Director/Board Member | 67 | 29.07.22 |
Owen Hughes
BRD | Director/Board Member | 49 | 20.11. |
Kenneth Anderson
FOU | Founder | 72 | 01.10.15 |
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14.09.20 |
Malcolm Salter
BRD | Director/Board Member | 84 | 01.12.15 |
Utpal Koppikar
BRD | Director/Board Member | 53 | 16.03.22 |
Laura Bessen
BRD | Director/Board Member | 61 | 29.07.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 68 600 669 | 60 834 824 ( 88,68 %) | 0 | 88,68 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+14.69% | 450 Mio. | |
+25.21% | 42.68 Mrd. | |
-2.56% | 42.4 Mrd. | |
+45.32% | 40.04 Mrd. | |
-6.20% | 28.31 Mrd. | |
+7.80% | 24.94 Mrd. | |
-20.09% | 18.96 Mrd. | |
+29.48% | 12.3 Mrd. | |
-2.66% | 11.95 Mrd. | |
-1.53% | 11.55 Mrd. |
- Börse
- Aktien
- A2QC0X Aktie
- Unternehmen C4 Therapeutics, Inc.